consent ranges from 3% to 57%. Is there a consensus on consent for biobanking when viewed from a broader perspective? Or do claims of consensus for broad consent refer instead to the agreement among biobanks about the appropriate consent approach ( Table 2 ; ref. 10)? We examined the evidence for consensus using content analysis to systematically assess the academic literature for arguments favoring different types of informed consent for biobanking.
the relevance of consensus
We want to emphasize that we are not suggesting that consensus is a precondition to the development of sound research ethics policy. Clearly, agreement on general principles or approaches would facilitate policy development, but consensus among academics or the public is not a prerequisite for policy-making 11 . Indeed, depending on the types of interests involved (for example, human rights claims), a majority view may be all but irrelevant. from thousands of participants for each future study. A logical consequence is to seek alternative approaches such as having a trusted intermediary that consents on behalf of the participant 3 or tiered consent in which participants choose from a checklist of items i n c l u d i n g , f o r example, type of research 4 . Although participant autonomy may be better preserved by these approaches, they require considerable resources and may limit the use of samples for some types of research.
By far the most common response to the consent dilemma has been to obtain an initial broad or blanket consent from research participants for a range of unspecified research activities 5, 6 . Not only is broad consent widely implemented by biobanks, but some within the ethical, legal and social issues (ELSI) community claim there is a consensus among scholars that broad consent is ethically and legally appropriate 5, 7, 8 .
Despite these claims, there is a great deal of diversity among national and international research ethics laws and policies, with some condemning broad consent and others providing tentative endorsement 9 . Likewise, public perception research shows that there is little consensus ( Table 1) : opinion favoring broad consent ranges from 34% to 79%, whereas opinion favoring specific Large-scale biobanks have emerged as a dominant data resource for biomedical research. Regions throughout the world have invested heavily in the creation of these research platforms. The UK Biobank is one of the most elaborate efforts, having already recruited 500,000 people (http://www. ukbiobank.ac.uk/), and Quebec, Sweden, Iceland, Denmark and Finland have also developed biobanks 1 .
Biobanks are viewed as necessary to tease out the complex and interrelated genetic and environmental factors that contribute to human disease. They allow for the repeated and long-term use of samples, and as such, they may require the long-term involvement of research participants and continued linkage between the biobank and the participant's health, lifestyle, genealogical and demographic information. These methodological approaches have generated tremendous ethical and social controversy. Although the social benefit of biobanking has been used to justify altering well-established consent norms, some have questioned the erosion of conventional legal rights for potential payoffs 2 .
Traditional consent norms and policies require that participants be fully informed of the nature and risks of the research. But because of the large number of participants and the long-term nature of biobanking, a specific-consent approach presents a substantial challenge. Indeed, it would be all but impossible to obtain specific consent Many scholars claim there is a consensus on broad consent for biobanking. We analyzed the literature in PubMed and found no evidence for consensus. Public perception studies report mixed findings on consent, but many biobanks adopt broad consent. A belief in consensus may stem from knowledge of biobank consent practices. Even if consensus is not necessary, it is useful to explore ethics and policy discord. First, variations on broad consent have emerged as the most common policy response to the consent dilemma 10 . It is worth exploring how and why this has happened. Second, understanding the degree and nature of disputes in this area can prepare us for future controversies and inform policy debates. There have already been a number of lawsuits concerning consent, privacy and data protection 12, 13 . These cases remind us that consent policy remains contested and highlight that some participants are not prepared to waive their right to give informed consent. npg were authors on 32% of the broad-consent articles (22 of 68 articles). Many of the pro-broad-consent articles (36.4%) had one or more authors who were associated with a biobank. This level of author affiliation with a biobank was not observed for the remaining consent categories (c 2 = 8.98, d.f. = 3, P < 0.05) (Fig.  1b) . These results indicate that informed consent and biobank association are not independent variables. Although we can only speculate why this correlation is occurring (perhaps, for example, because of better knowledge of biobanking practices), this phenomenon would add to the perception within the biobanking community of a consensus around the issue of consent.
An article count of this nature has clear limitations. Publication trends are influenced by publication opportunities, such as invited commentaries. In addition, our sampling method using PubMed is not that reported on stakeholder perceptions but did not argue in favor of any specific approach to consent. Of the 470 fully analyzed articles, 132 articles coded for one of the four consent categories: 51% broad (68 articles), 13% specific (17 articles), 16% other (21 articles) and 20% neutral (26 articles) (c 2 = 50.73, d.f. = 3, P < 0.0001) (Fig. 1a) . Specifically, 231 authors wrote 68 articles arguing for broad consent, 38 authors wrote 17 articles arguing for specific consent, 59 authors wrote 21 articles arguing for other consent and 85 authors wrote 26 articles that were argumentatively neutral. A Cohen's kappa score of 0.80 indicated excellent intercoder reliability. Our results indicate that although many articles argue for broad consent, there is no general agreement in the literature favoring broad consent over other forms. This lack of consensus becomes more apparent when it is acknowledged that two scholars advantages and disadvantages of different consent approaches but remain argumentatively neutral and inconclusive as to the preferred model. This is ethically significant as it shows that some authors are not prepared to conclude on one consent type.
coding for biobank association
We subsequently analyzed coded articles to determine whether one or more authors were associated with a biobank through four steps: (i) we examined the article's author affiliations, acknowledgments and conflict of interests sections; and we performed author name searches using (ii) Scopus (http://www.scopus.com/), (iii) LinkedIn (http://www.linkedin.com/) and (iv) Google (http://www.google.ca/) (with or without the words 'CV' , 'bio' and 'biobank') to identify author affiliations with different organizations. We analyzed biographies, CVs and other relevant documents to identify author association with a biobank. Articles were marked as having a positive association with a biobank if one or more authors were members of a board of governors or directors, advisory board or working group of a biobank; if the authors were paid or unpaid staff of a biobank; or if the authors' research was funded by a biobank, a biotech company who runs a biobank, or an organization that is partnered or funded by a biobank.
statistical analysis
To test for reliability among coders, 13% of 395 articles from an initial set (comprising articles published until November 2010) were randomly selected and analyzed by a second coder. Differences in the interpretation of the coding categories were discussed to reach a common understanding, and the revised coding framework was reapplied to the entire data set. Statistical determination of intercoder reliability was determined using Cohen's kappa coefficient 14 .
As we counted the number of articles in different consent categories, we performed Pearson's chi-squared (c 2 ) analyses using SPSS v.19 software (IBM) for Windows to determine whether our observed counts fit to an expected distribution. a lack of consensus on consent Most of the analyzed articles were irrelevant because they did not discuss or argue which informed-consent model is appropriate for biobanking. Examples of irrelevant articles include those that described how consent was obtained for a particular study or those 
